Xiaohua Gong
Shenzhen Key Laboratory Of Pathogen And Immunity, State Key Discipline Of Infectious Disease, Shenzhen
Guangzhou, 518112, China
Guangzhou, 518112, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Targeting PRMT7-mediated monomethylation of MAVS enhances antiviral innate immune responses and inhibits RNA virus replication.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 15, 2024
Identification of mpox M1R and B6R monoclonal and bispecific antibodies that efficiently neutralize authentic mpox virus.
Journal: Emerging microbes & infections
Published: September 05, 2024
Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
Journal: The Journal of infection
Published: April 26, 2024
Development of Glycan-masked SARS-CoV-2 RBD vaccines against SARS-related coronaviruses.
Journal: PLoS pathogens
Published: March 27, 2024
Plasma 25-hydroxyvitamin D deficiency in the peri-operative period is associated with survival outcome in colorectal cancer patients: a meta-analysis.
Journal: BMC surgery
Published: March 08, 2024
Evolutionary trajectory and characteristics of Mpox virus in 2023 based on a large-scale genomic surveillance in Shenzhen, China.
Journal: Nature communications
Published: March 08, 2024
A novel nanobody broadly neutralizes SARS-CoV-2 via induction of spike trimer dimers conformation.
Journal: Exploration (Beijing, China)
Published: July 04, 2023
Naive and breakthrough infections with BA.2, BA.5 and BF.7 variants provide poor cross protection against XBB related variants.
Journal: The Journal of infection
Published: May 15, 2023
The impact of multidisciplinary team nutrition management on nutritional and toxicity status in patients with nasopharyngeal carcinoma.
Journal: Asia-Pacific journal of oncology nursing
Published: December 03, 2022
Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2.
Journal: Signal transduction and targeted therapy
Published: June 19, 2022
An Efficient Modern Strategy to Screen Drug Candidates Targeting RdRp of SARS-CoV-2 With Potentially High Selectivity and Specificity.
Journal: Frontiers in chemistry
Published: May 05, 2022
Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees.
Journal: The Journal of infection
Published: December 30, 2021
Last Updated: 09/26/2026